Formosa Laboratories Inc Cash Flow Conversion Efficiency
Formosa Laboratories Inc cash flow conversion efficiency. Based on the latest financial reports, Formosa Laboratories Inc (4746) has a cash flow conversion efficiency ratio of 0.018x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$156.90 Million ≈ $4.94 Million USD) by net assets (NT$8.68 Billion ≈ $273.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Formosa Laboratories Inc (4746) market capitalisation for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Formosa Laboratories Inc (2009–2025)
Cash flow conversion efficiency of Formosa Laboratories Inc from 2009 to 2025. This chart illustrates how Formosa Laboratories Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Formosa Laboratories Inc stock quote for real-time trading data and today's change.
Formosa Laboratories Inc Cash Flow Conversion Ratio Explained
Formosa Laboratories Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Formosa Laboratories Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Formosa Laboratories Inc ranked by their cash flow conversion efficiency. Review Formosa Laboratories Inc free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Thrace Plastics Holding and Commercial S.A
AT:PLAT
|
0.033x |
|
Sri Rejeki Isman(Sritex)PT
JK:SRIL
|
0.007x |
|
Aplicaciones y Tratamiento de Sistemas S.A.
MC:ATSI
|
0.029x |
|
BV Financial, Inc. Common Stock
NASDAQ:BVFL
|
0.019x |
|
Krsnaa Diagnostics Limited
NSE:KRSNAA
|
0.056x |
|
Patriot Acquisition Corp.
NASDAQ:PTAC
|
-0.003x |
|
BANK OF JIUJIANG H YC1
F:BJ8
|
N/A |
|
CMC Corp
VN:CMG
|
0.060x |
Annual Cash Flow Conversion Efficiency for Formosa Laboratories Inc (2009–2025)
The table below shows the annual cash flow conversion efficiency of Formosa Laboratories Inc from 2009 to 2025. Also see total assets of Formosa Laboratories Inc for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$8.67 Billion ≈ $273.16 Million |
NT$1.32 Billion ≈ $41.44 Million |
0.152x | +80.59% |
| 2024-12-31 | NT$8.65 Billion ≈ $272.42 Million |
NT$726.33 Million ≈ $22.88 Million |
0.084x | -16.57% |
| 2023-12-31 | NT$8.21 Billion ≈ $258.67 Million |
NT$826.60 Million ≈ $26.04 Million |
0.101x | +22.06% |
| 2022-12-31 | NT$7.80 Billion ≈ $245.63 Million |
NT$643.09 Million ≈ $20.26 Million |
0.082x | +101.53% |
| 2021-12-31 | NT$7.60 Billion ≈ $239.51 Million |
NT$311.16 Million ≈ $9.80 Million |
0.041x | -54.45% |
| 2020-12-31 | NT$5.29 Billion ≈ $166.53 Million |
NT$475.00 Million ≈ $14.97 Million |
0.090x | +38.16% |
| 2019-12-31 | NT$4.46 Billion ≈ $140.43 Million |
NT$289.92 Million ≈ $9.13 Million |
0.065x | +466.48% |
| 2018-12-31 | NT$4.56 Billion ≈ $143.60 Million |
NT$-80.89 Million ≈ $-2.55 Million |
-0.018x | -118.41% |
| 2017-12-31 | NT$4.10 Billion ≈ $129.20 Million |
NT$395.42 Million ≈ $12.46 Million |
0.096x | -64.36% |
| 2016-12-31 | NT$4.10 Billion ≈ $129.29 Million |
NT$1.11 Billion ≈ $34.97 Million |
0.271x | +267.07% |
| 2015-12-31 | NT$3.46 Billion ≈ $109.08 Million |
NT$255.15 Million ≈ $8.04 Million |
0.074x | -20.23% |
| 2014-12-31 | NT$3.04 Billion ≈ $95.63 Million |
NT$280.41 Million ≈ $8.83 Million |
0.092x | +620.58% |
| 2013-12-31 | NT$2.52 Billion ≈ $79.26 Million |
NT$32.25 Million ≈ $1.02 Million |
0.013x | -87.46% |
| 2012-12-31 | NT$1.67 Billion ≈ $52.75 Million |
NT$171.13 Million ≈ $5.39 Million |
0.102x | +1810.84% |
| 2011-12-31 | NT$1.88 Billion ≈ $59.23 Million |
NT$-11.23 Million ≈ $-353.84K |
-0.006x | -108.35% |
| 2010-12-31 | NT$1.39 Billion ≈ $43.90 Million |
NT$99.67 Million ≈ $3.14 Million |
0.072x | -79.01% |
| 2009-12-31 | NT$1.33 Billion ≈ $41.98 Million |
NT$454.22 Million ≈ $14.31 Million |
0.341x | -- |
About Formosa Laboratories Inc
Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. It offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomo… Read more